NL-OMON51293招募中不适用
Real-time MR imaged treatment with holmium microspheres of patients with primary liver cancer; a single center, interventional, non-randomized, feasibility study - EMERITUS-2
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Diagnosis of hepatocellular carcinoma BCLC stage B or C
- •2. At least one lesion of 10 mm or more in the longest diameter on
- •contrast-enhanced MRI/CT
- •3. Patient is eligible for TARE as determined by the tumour board (in Dutch:
- •4. Patient has a life expectancy of 12 weeks or longer
- •5. Patient has a WHO performance score of 0-2
排除标准
- •1. Extrahepatic disease that cannot be targeted during the TARE session
- •(enlarged lymph nodes in the liver hilus are allowed)
- •2. Radiation therapy, chemotherapy or major surgery within 4 weeks before
- •3. Serum bilirubin > 2.0 x the upper limit of normal
- •4. ALAT, ASAT, alkaline phosphatase (AF) > 5x the upper limit of normal
- •5. Glomerular filtration rate (GFR-MDRD) <35 ml/min
- •6. Leukocytes <4.0 * 109/L or platelet count <60 * 109/L
- •7. Significant heart disease that in the opinion of the physician increases the
- •risk of ventricular arrhythmia.
- •8. Pregnancy or breast feeding
- •9. Disease with increased chance of liver toxicity, such as primary biliary
- •cirrhosis or xeroderma pigmentosum
- •10. Patients ineligible to undergo MR-imaging (claustrophobia, metal implants,
- •11. Portal vein thrombosis of the main branch (more distal branches are allowed)
- •12. Evidence of clinically relevant, untreated portal hypertension combined
- •with grade 3 oesophageal varices
- •13. Untreated, active hepatitis
- •14. Body weight > 150 kg (because of maximum table load)
- •15. Severe allergy for i.v. contrast (Iomeron, Dotarem and/or Primovist)
- •16. Lung shunt > 30 Gy, as calculated using scout dose 166Ho SPECT/CT.
- •17. Uncorrectable extrahepatic deposition of scout dose activity. Activity in
- •the falciform ligament, portal lymph nodes or gallbladder are accepted.
- •18. Unstable final catheter position due to hepatic artery anatomy, which might
- •lead to dislocation of the catheter during transfer to the MRI.
研究者
相似试验
已完成
不适用
Real-time MR imaged treatment with holmium microspheres of patients with primary or secondary liver cancer; a single center, interventional, non-randomized, feasibility study.liver cancerHepatocellular carcinomaNL-OMON45742Radboud Universitair Medisch Centrum6
已完成
不适用
Real-time Imaging of Holmium Radioembolization: a Feasibility StudyLiver MetastasesLiver CancerNCT04269499Radboud University Medical Center6
Enrolling By Invitation
不适用
MRI-guided Holmium-166 RadioembolizationPrimary Liver CancerNon-Resectable Hepatocellular CarcinomaNCT05609448Radboud University Medical Center15
尚未招募
不适用
Application of MRI in patients with non-alcoholic fatty liver diseaseKCT0004307Hanyang University Seoul Hospital100
招募中
不适用
Magnetic Resonance imaging-guided high intensity focused ultrasound for patients with Desmoid-type fibromatosisaggressive fibromatosisDesmoid tumour1007299010041297NL-OMON54042niversitair Medisch Centrum Utrecht13